1. Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study. Issue 5 (May 2022) Authors: Sridhar, Saranya; Joaquin, Arnel; Bonaparte, Matthew I; Bueso, Agustin; Chabanon, Anne-Laure; Chen, Aiying; Chicz, Roman M; Diemert, David; Essink, Brandon J; Fu, Bo; Grunenberg, Nicole A; Janosczyk, Helene; Keefer, Michael C; Rivera M, Doris M; Meng, Ya; Michael, Nelson L; Munsiff, Sonal S; Ogbu... Journal: Lancet infectious diseases Issue: Volume 22:Issue 5(2022) Page Start: 636 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗